drugset / Trial / NCT00491868
Clinical Study of R744 to Hemodialysis Patients
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study used as the comparative drug (epoetin beta) will assess the efficacy and safety of intravenous injections of R744 in renal anemia patients on Hemodialysis patients.
Timeline
- Start
- 2007-06
- Primary completion
- 2008-05
- Completion
- 2008-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | methoxy polyethylene glycol-epoetin beta | Protein / enzyme biologic | 50 ug | Intravenous |
| Subject | methoxy polyethylene glycol-epoetin beta | Protein / enzyme biologic | 250 ug | Intravenous |
| Subject | rHuEPO | Protein / enzyme biologic | 750 iu | Intravenous |
| Subject | rHuEPO | Protein / enzyme biologic | 9000 iu | Intravenous |
Indications
No indication recorded.